Cafepharma Today

April 19 2024 - Roche wins FDA OK for targeted drug in early lung cancer
Roche wins FDA OK for targeted drug in early lung cancer
How Vir found the one: CEO Marianne De Backer
Ozempic's latest reported side effect: pregnancy
FDA mandates label updates on CAR-T cancer therapies
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. Drug Sales Projected to Decline This Year
WSJ Online
Thursday, April 23, 2009 - 9:50am
tags:
drug sales
FDA Calendar Updates: Diabetes
Seeking Alpha
Thursday, April 23, 2009 - 9:48am
tags:
FDA, diabetes, Bristol-Myers Squibb, AstraZeneca, Onglyza, alogliptin, Takeda, Novo Nordisk, Victoza
Solvay: Yes, we're reviewing our strategies
Fierce Pharma
Thursday, April 23, 2009 - 9:27am
tags:
Solvay
Gilead Sciences: A Biotech No More
Seeking Alpha
Thursday, April 23, 2009 - 9:26am
tags:
Gilead Sciences, biotech
Pay for Performance for Prescription Drugs (Or Maybe Not)
WSJ Online
Thursday, April 23, 2009 - 9:22am
tags:
Januvia, Cigna, Merck, diabetes
Teva acquisition rumor pushes Watson trade
Globes,Israel
Thursday, April 23, 2009 - 8:31am
tags:
Teva Pharmaceuticals, Watson Pharmaceuticals, buyouts
Bristol-Myers, AstraZeneca drug approval delayed
Marketwatch
Thursday, April 23, 2009 - 8:26am
tags:
Bristol-Myers Squibb, FDA, AstraZeneca, Onglyza, diabetes
Sanofi-Aventis CEO: China key for future growth
Yahoo/AP
Thursday, April 23, 2009 - 6:49am
tags:
China, Pharma CEOs, Sanofi, Chris Viehbacher
Novartis posts 14 percent drop in 1Q profit
Yahoo/AP
Thursday, April 23, 2009 - 6:48am
tags:
Novartis, earnings
Icahn, Amylin fail to on settlement in proxy fight
Yahoo/AP
Wednesday, April 22, 2009 - 9:14pm
tags:
Carl Icahn, Amylin, Eli Lilly
Lilly: Court blocks Teva's generic Evista
Marketwatch
Wednesday, April 22, 2009 - 9:12pm
tags:
Teva Pharmaceuticals, Eli Lilly, generics, Evista
Baxter A Healthy Healthcare Holding
Investopedia
Wednesday, April 22, 2009 - 5:12pm
tags:
Baxter International
Report: Drug sales to fall in US, slow elsewhere
Yahoo/AP
Wednesday, April 22, 2009 - 4:08pm
tags:
drug sales
Official: FDA to OK Plan B for 17-year-olds
Google/AP
Wednesday, April 22, 2009 - 3:50pm
tags:
FDA, birth control, Plan B contraceptive, Teva Pharmaceuticals
Illumina shares fall following 1Q results
Yahoo/AP
Wednesday, April 22, 2009 - 3:42pm
tags:
Illumina, earnings
5-Star Stocks Poised to Pop: Forest Labs
Motley Fool
Wednesday, April 22, 2009 - 3:31pm
tags:
Forest Labs
Does Avastin Trial Mean Roche Paid Too Much for Genentech?
WSJ Online
Wednesday, April 22, 2009 - 11:27am
tags:
Roche, cancer, Genentech, drug trials, Avastin
Elan CEO says favors big pharma tie-up
Reuters
Wednesday, April 22, 2009 - 11:26am
tags:
Elan, M&A, Kelly Martin
Amylin: A Discounted Option on Byetta's Outcome
Seeking Alpha
Wednesday, April 22, 2009 - 11:25am
tags:
Amylin, diabetes, Byetta
Amgen Earnings: This May Hurt
TheStreet.com
Wednesday, April 22, 2009 - 11:22am
tags:
Amgen, earnings

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Account Executive - Hospice
Buckner, MO, 64016
Agape Care Group
Account Executive - Hospice
Bates City, MO, 64011
Agape Care Group
Account Executive - Hospice
Kansas City, MO, 64171
Agape Care Group
Account Executive - Hospice
East Lynne, MO, 64743
Agape Care Group
Account Executive - Hospice
Mosby, MO, 64073
Agape Care Group
Account Executive - Hospice
Excelsior Springs, MO, 64024
Agape Care Group
Account Executive - Hospice
Warrensburg, MO, 64093
Agape Care Group
Account Executive - Hospice
Odessa, MO, 64076
Agape Care Group
Account Executive - Hospice
Henrietta, MO, 64036
Agape Care Group
Account Executive - Hospice
Knob Noster, MO, 65336
Agape Care Group
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information